Latest News
19-Sep-2025 After Mounjaro Jab, Eli Lilly to Launch Weight Loss Pill in India
19-Sep-2025 PMO Acts on Pharma MSMEs ‘Crisis Call’
18-Sep-2025 NCB Highlights Six-Fold Rise in Synthetic Drugs
11-Sep-2025 HC Stays Drug Regulator’s Action Against IndiaMart
10-Sep-2025 More Patients Can Access Key Drugs After Tax Cuts
  more...
Latest Reports
Sep-25 Scaling capacity ahead of Semaglutide patent expiry - Motilal Oswal  
Aug-25 IPM: 7% value and 2% unit decline in Jul-25 - HDFC Securities  
Jul-25 Jun-25: IPM rebounds; Glenmark shining - Nuvama  
Jul-25 1QFY26 Preview: gRevlimid pricing pressures + late IPM surge - Emkay Research  
Jul-25 IPM: 11.5% value and 5% unit growth in Jun’25 - HDFC Securities  
  more...

Quarterly Summary June-2025
Desc Current Previous Per.Chg
Sales 72470.4 65585.7 10.5
Otherincome 2644.2 1897.0 39.4
Expense 51971.3 49147.6 5.7
RawMaterial 20024.7 18823.0 6.4
StaffCost 11094.3 10095.5 9.9
ExciseDuty 81.0 75.1 7.8
OtherExp 15645.7 15165.0 3.2
Interest 1230.9 1079.5 14.0
GrossProfit 23043.0 18465.4 24.8
Depreciation 2940.4 2761.9 6.5
Tax 4527.1 3667.4 23.4
NetProfit 14847.4 11957.8 24.2
Total.Comp 181 -- --
Source: ETIG Database

Sectoral Companies As on 19 Sep 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 397336.08
Divi's Lab 164543.16
Cipla 127256.97
Torrent Phar 122896.03
Dr.Reddy's 110392.54
Mankind Phar 109846.08
Zydus Life 104342.94
Lupin 93916.93
Alkem Labora 66162.56
Aurobindo Ph 65524.13
Abbott (I) 64386.23
Glenmark Pha 58827.41
Laurus Labs 50295.87
  click here for the complete list